Study aims to spare bladders from surgery in cancer fight
NCT ID NCT01495676
Summary
This study tested two different combinations of chemotherapy drugs given alongside radiation therapy for people with muscle-invasive bladder cancer. The goal was to see if adding a drug called gemcitabine to the standard treatment (radiation plus cisplatin) could better control the cancer and help patients keep their bladder, avoiding major surgery. It enrolled 69 participants but was terminated early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFILTRATING BLADDER UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRLC GF Leclerc
Dijon, 21000, France
-
CRLC Val d'Aurelle-Paul Lamarque
Montpellier, 34000, France
-
Centre Alexis Vautrin
Vandœuvre-lès-Nancy, 54511, France
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Francois Baclesse
Caen, 14000, France
-
Centre azuréen de Cancérologie
Mougins, 06250, France
-
Clinique Patseur
Toulouse, 31300, France
-
HEGP
Paris, 75015, France
-
Hopital Henri Mondor
Créteil, 94010, France
-
Hopital saint Louis
Paris, 75010, France
-
Institut Bergonié
Bordeaux, 33000, France
-
Institut de Cancérologie Lucien Neuwirth
Saint-Priest-en-Jarez, 42705, France
Conditions
Explore the condition pages connected to this study.